DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Glucose Monitoring Devices Market: Trends, Opportunities and Forecasts (2016-2021)" report to their offering.
Global Glucose Monitoring Devices market is forecast to grow at a CAGR of 6.52% during 2016 - 2021F, driven by the increasing number of diabetic patients as a consequence of sedentary lifestyles. As per capita healthcare expenditure is rising along with the growth in the disposable income, it has resulted in increasing healthcare spending including expenditure on diabetes.
Growth in the prevalence of diabetes among the population coupled with growing focus on technology has resulted in the rising of market for glucose monitoring devices globally.
While blood glucose monitors are holding major market globally due to its prominence and affordability among the emerging nations, technological advancements have led to the growth of Continuous Glucose Monitoring devices which is expected to grow faster in the future. Among the regions, North America holds the major market due to the higher disposable income as well as insurance coverage. However, among emerging markets, Asia Pacific is expected to grow the highest due to the growth in aging population as well as per capita expenditure.
In 2016, market for Continuous Glucose Monitoring is expected to grow at a faster pace due to the non-invasiveness as well as increasing adoptability mainly in developed regions.
Scope of the Report
- Global Glucose Monitoring device market size, Share & Forecast
- Device Types - Blood Glucose Monitoring Devices and Continuous Glucose Monitoring Devices
- Regional Analysis - North America, Latin America, Asia Pacific, Africa, Europe, Middle East
- Country Analysis - United States, Canada, Brazil, Chile, South Africa, India, China, United Kingdom, Germany
- Policy & Regulatory Landscape
- Changing Market Trends & Emerging Opportunities
- Competitive Landscape & Strategic Recommendations
Key Topics Covered:
1. Research Methodology
2. Product Overview
3. Executive Summary
4. Global Glucose Monitoring Devices Market: An Analysis
5. Europe Glucose Monitoring Devices Market: An Analysis
6. Asia Pacific Glucose Monitoring Devices Market: An Analysis
7. North America Glucose Monitoring Devices Market: An Analysis
8. Latin America Glucose Monitoring Devices Market: An Analysis
9. Africa Glucose Monitoring Devices Market: An Analysis
10. Middle East Glucose Monitoring Devices Market: An Analysis
11. Regulatory Overview
12. Market Dynamics
14. Competitive Landscape
14.1. Competitive Benchmarking
15. Company Profiling
- Abbott Laboratories
- Arkray, Inc.
- Bayer Healthcare AG
- Bionime Corp.
- DexCom Inc.
- F. Hoffmann-La Roche AG
- LifeScan, a Johnson & Johnson Company
- Medtronic Inc.
- Novo Nordisk
- Ypsomed AG
For more information visit http://www.researchandmarkets.com/research/jtstlv/global_glucose